Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies. [electronic resource]
Producer: 20200831Description: 2096-2111 p. digitalISSN:- 1461-7005
- Autism Spectrum Disorder -- drug therapy
- Child
- Delayed-Action Preparations
- Double-Blind Method
- Early Termination of Clinical Trials
- Excitatory Amino Acid Antagonists -- therapeutic use
- Female
- Fever -- chemically induced
- Headache -- chemically induced
- Humans
- Irritable Mood
- Male
- Memantine -- therapeutic use
- Nasopharyngitis -- chemically induced
- Social Behavior
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.